SCHULMAN AMY W Insider Trades

Insider Trading History

Track insider trading activity for SCHULMAN AMY W. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $6.93M 24,049 shares
Last Trade
May 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$788k 2,640 shares
$298.48
$288.18
Elevance Health
Elevance Health ELV
Director
Holding Value $309k 781 shares
Last Trade
May 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$225k 563 shares
$399.64
$395.10
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $0 0 shares
Last Trade
May 13, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.28M 11,250 shares
$291.48
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $6.69M 23,211 shares
Last Trade
May 13, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.28M 11,250 shares
$291.48
$288.18
Elevance Health
Elevance Health ELV
Director
Holding Value $86.1k 218 shares
Last Trade
Mar 12, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.48k 26 shares
$287.50
$395.10
Elevance Health
Elevance Health ELV
Director
Holding Value $86.1k 218 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$74.5k 218 shares
$341.83
$395.10
Fractyl Health
Fractyl Health GUTS
Director
Holding Value $18.6k 22,500 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$51.1k 22,500 shares
$2.27
$0.83
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $3.45M 11,961 shares
Last Trade
May 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$403k 1,558 shares
$258.35
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $0 0 shares
Last Trade
Mar 13, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$665k 2,750 shares
$241.75
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $3.22M 11,186 shares
Last Trade
Mar 13, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$665k 2,750 shares
$241.75
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $2.43M 8,436 shares
Last Trade
Jun 25, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.04M 8,500 shares
$240.00
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $792k 2,750 shares
Last Trade
Jun 25, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.04M 8,500 shares
$240.15
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $4.88M 16,936 shares
Last Trade
Jun 25, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.04M 8,500 shares
$240.15
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $0 0 shares
Last Trade
May 29, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.41M 30,000 shares
$146.93
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $5.77M 20,015 shares
Last Trade
May 29, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.22M 21,700 shares
$148.60
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $8.68M 30,136 shares
Last Trade
May 29, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.41M 30,000 shares
$146.93
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $1.51M 5,228 shares
Last Trade
May 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$791k 5,228 shares
$151.22
$288.18
SQZ Biotechnologies
SQZ Biotechnologies SQZ
10% owner
Holding Value $17.3k 39,875 shares
Last Trade
Jun 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.5k 39,875 shares
$0.54
$0.44
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $995k 3,454 shares
Last Trade
May 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$656k 3,454 shares
$189.87
$288.18
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $39.2k 136 shares
Last Trade
Feb 23, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.7k 136 shares
$196.24
$288.18

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up